Contribution of 30 Biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving and monograph (MORGAM) biomarker project

Background— Cardiovascular risk estimation by novel biomarkers needs assessment in disease-free population cohorts, followed up for incident cardiovascular events, assaying the serum and plasma archived at baseline. We report results from 2 cohorts in such a continuing study.
Methods and Results— Thirty novel biomarkers from different pathophysiological pathways were evaluated in 7915 men and women of the FINRISK97 population cohort with 538 incident cardiovascular events at 10 years (fatal or nonfatal coronary or stroke events), from which a biomarker score was developed and then validated in the 2551 men of the Belfast Prospective Epidemiological Study of Myocardial Infarction (PRIME) cohort (260 events). No single biomarker consistently improved risk estimation in FINRISK97 men and FINRISK97 women and the Belfast PRIME Men cohort after allowing for confounding factors; however, the strongest associations (with hazard ratio per SD in FINRISK97 men) were found for N-terminal pro-brain natriuretic peptide (1.23), C-reactive protein (1.23), B-type natriuretic peptide (1.19), and sensitive troponin I (1.18). A biomarker score was developed from the FINRISK97 cohort with the use of regression coefficients and lasso methods, with selection of troponin I, C-reactive protein, and N-terminal pro-brain natriuretic peptide. Adding this score to a conventional risk factor model in the Belfast PRIME Men cohort validated it by improved c-statistics (P=0.004) and integrated discrimination (P<0.0001) and led to significant reclassification of individuals into risk categories (P=0.0008).
Conclusions— The addition of a biomarker score including N-terminal pro-brain natriuretic peptide, C-reactive protein, and sensitive troponin I to a conventional risk model improved 10-year risk estimation for cardiovascular events in 2 middle-aged European populations. Further validation is needed in other populations and age groups.

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

The novel long-acting β2-agonist olodaterol demonstrated an acceptable safety profile in short-term phase II clinical studies. This analysis of four randomized, double-blind, placebo-controlled, parallel-group, phase III studies (1222.11, NCT00782210; 1222.12, NCT00782509; 1222.13, NCT00793624; 1222.14, NCT00796653) evaluated the long-term safety of olodaterol once daily (QD) in a large cohort of patients with moderate to very severe (Global initiative for chronic Obstructive Lung Disease 2-4) chronic obstructive pulmonary disease (COPD). The studies compared olodaterol (5 or 10 μg) QD via Respimat®, formoterol 12 μg twice daily (BID) via Aerolizer® (1222.13 and 1222.14), and placebo for 48 weeks. Patients continued receiving background maintenance therapy, with ∼60% receiving concomitant cardiovascular therapy and 25% having a history of concomitant cardiac disease. Pre-specified analyses of pooled data assessed the adverse events (AEs) and serious AEs in the whole population, and in subgroups with cardiac disease, along with in-depth electrocardiogram and Holter monitoring. In total, 3104 patients were included in the safety analysis: 876 received olodaterol 5 μg, 883 received olodaterol 10 μg, 885 received placebos, and 460 received formoterol 12 μg BID. Overall incidence of on-treatment AEs (71.2%), serious AEs (16.1%), and deaths (1.7%) were balanced across treatment groups. Respiratory and cardiovascular AEs, including major adverse cardiac events, were reported at similar frequencies in placebo and active treatment groups. The safety profiles of both olodaterol 5 μg (marketed and registered dose) and 10 μg QD delivered via Respimat® are comparable to placebo and formoterol BID in this population, with no safety signals identified.

Engineering Foundation Year Sustaining Success Lecture 2

Lecture notes for skills module Routes to Success: Sustaining Success Lecture 2. Portfolio building

Engineering Foundation Year - Routes to Success - Sustaining Success - lecture 2

skills module, developing student skills by creating portfolio.

Collection Engineering Foundation Year, Sustaining Success, Week 2

slidses, portfolio template, portfolio summary, example feedback, video link

Engineering Foundation Year - Routes to Success - Sustaining Success - lecture 2 6up slides

skills module, developing student skills by creating portfolio.

Collection Foundation Year RTS Part 3 Week 2 AY2012-13

reading for private study during week 2, to be used in conjunction with week 1 collection

Rat-a-tat-tat : phonics workbook : year 2.

Para ofrecer una progresiva enseñanza de la fonética, basándose en los libros de imágenes utilizados en la serie de Canal Cuatro. En la página izquierda se presenta una parte de un libro de imágenes que aparecen en la serie de televisión, para que el profesor, en la página de la derecha, proponga ejercicios de fonética, según el texto, avanzando en dificultad a través de los tres años de la etapa para cinco a siete años. La enseñanza fónica coincide exactamente con la secuencia de la Estrategia Nacional de Lectura. También puede utilizarse de forma independiente. Para discriminar, escribir y leer la ortografía común de los patrones de fonemas OO, AR, OY, OW, AIR, OR, ER, EAR, EA.

100 maths framework lessons : Year 1 : Scottish primary 2.

Recurso que ayuda a los profesores a vincular sus conocimientos a los aspectos clave del aprendizaje y del currículo. Está estructurado en cinco bloques que forman el marco principal renovado para Matemáticas. Cada uno de ellos consta de tres unidades que cubren un texto diferente dentro del bloque. Las unidades se enseñan en un número determinado de semanas que, a su vez, se dividen en días o lecciones. Una de las características principales del recurso es la flexibilidad de su estructura que permitirá a los profesores adaptarse a las necesidades de cada niño. Cuenta con un CD-ROM que incluye recursos multimedia como vídeo, audio, imágenes, actividades interactivas y páginas fotocopiables.